Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,179.80 +109.67 0.73%
S&P 500 1,639.04 +12.31 0.76%
Nasdaq 3,452.13 +28.58 0.83%
Ticker Volume Price Price Delta
STOXX 50 2,702.69 +35.37 1.33%
FTSE 100 6,330.49 +22.23 0.35%
DAX 8,215.73 +87.77 1.08%
Ticker Volume Price Price Delta
Nikkei 13,007.30 -25.84 -0.20%
Hang Seng 21,185.00 -40.92 -0.19%
S&P/ASX 200 4,814.35 -11.53 -0.24%
  • Fund Type: FCP
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: Global

DekaLux-PharmaTech

+ Add to Watchlist

DKXPHTF:LX

161.51 EUR 0.75 0.47%

As of 00:59:30 ET on 06/17/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for DekaLux-PharmaTech (DKXPHTF)

Year To Date: +17.95% 3-Month: +4.48% 3-Year: +12.20% 52-Week Range: 130.76 - 169.83
1-Month: -4.07% 1-Year: +23.76% 5-Year: +10.66% Beta vs LUXXX: 0.59

Mutual Fund Chart for DKXPHTF

No chart data available.
  • DKXPHTF:LX 161.51
  • 1M
  • 1Y
Interactive DKXPHTF Chart

Previous Close

Fund Profile & Information for DKXPHTF

DekaLux-PharmaTech is an open-end fund incorporated in Luxembourg. The Fund's objective is growth and income. The Fund invests in global companies involved in growth sectors such as pharmaceuticals, biotechnology, medtech, and healthcare.

Inception Date: 06-02-2008 Telephone: 352-3409-39
Managers: ANDRE LEUE
Web Site: www.deka.de

Fundamentals for DKXPHTF

NAV (on 2013-06-17) 161.51
Assets (M) (on 2013-06-17) 225.40
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for DKXPHTF

Dividend Type Accumulation
Dividend Frequency Annual
Last Dividend Net (on 2012-07-02) 0.66
Dividend Yield (ttm) 0.41

Fees & Expenses for DKXPHTF

Front Load 0.00
Back Load -
Current Mgmt Fee 0.18
Redemption Fee -
12b1 Fee -
Expense Ratio 2.23

Top Fund Holdings for DKXPHTF

Filing Date: 12/28/2012
Name Position Value % of Total
Johnson & Johnson 255,247 13,528,836 7.043%
Pfizer Inc 699,326 13,295,010 6.921%
Novartis AG 214,300 10,248,202 5.335%
Roche Holding AG 66,280 10,166,931 5.293%
Merck & Co Inc 284,374 8,859,941 4.612%
Sanofi 109,800 7,837,524 4.080%
GlaxoSmithKline PLC 463,700 7,642,498 3.978%
Abbott Laboratories 149,700 7,363,984 3.833%
Bayer AG 75,200 5,442,224 2.833%
Novo Nordisk A/S 38,530 4,736,115 2.465%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil